Marek Kozlowski

Senior Investment Director - NRW.Venture (NRW.BANK), Germany

Marek has been working in venture capital for three years, focusing on therapeutic, diagnostic and research tools. Marek’s venture capital activities are based on his 10 years of experience in interdisciplinary basic research at Harvard Medical School, Boston Children’s Hospital, the European Molecular Biology Laboratory (EMBL) and the Biomedical Centre in Munich.

Previously Marek was also responsible for business development in Molecular Biology at ITOCHU and AJINOMOTO.
Marek received his doctorate in Molecular Biology from LMU Munich and EMBL. He holds an M.Sc. Eng. In Biotechnology from the University of Warsaw.

Managed portfolio companies: Abalos Therapeutics, 4TEEN4 Pharmaceuticals, Emergence Therapeutics, Resolve BioSciences.

Cécile Cavalade

Business Development Manager, ULB-TTO, Université libre de Bruxelles, Belgium
Alessandra Baccigotti

Chair of the Europe Committee

Knowledge Transfer Manager, Intellectual Property Protection Unit of the Knowledge…
Maria Martshenko

Senior Specialist in Product Innovation at Tallinn University, School of Natural…
Ingrid Hindrikson

Expert of Business Partnership at Tallinn University, Centre of Knowledge Transfer…
Mari-Liis Leinus

Head of Testing Laboratory of Chemical Analysis at Institute of Natural Sciences…
Laura Furlong

Laura is one of the co-founders and CSO of MedBioInformatics Solutions SL.
Krystian Gurba

Deputy Director, Centre for Technology Transfer CITTRU, Jagiellonian University in…
Signe Ratso

Deputy Director-General and a member of the Management Board of the Directorate-General…
Nadežda Kongi

Associate Professor at the University of Tartu
Mart Maasik

Head of Entrepreneurship at the University of Tartu, Estonia

Speakers

Marek Kozlowski

Subscribe to our newsletter